Nuestros recursos

In the first of our two-part series exploring minority participation in clinical trial research, we examine the numerous challenges to securing diversity in clinical trials and the consequences of primarily white patient populations.

ObvioHealth, a global virtual research organization (VRO), announces the launch of its cutting-edge patient engagement suite, designed to motivate and support decentralized clinical trial patients from the moment of recruitment through study completion. These patient-centric products and services, deployed through ObvioHealth’s powerful ObvioGo platform and app, significantly increase clinical trial compliance and retention while also delivering more accurate and real-time data.

ObvioHealth tackles misconceptions about decentralized clinical trials, they’re less safe, they’re always fully virtual, the data isn’t trustworthy, and so on.

ObvioHealth, a pioneering virtual research organization (VRO), announces the launch of ObvioGo, a next-generation decentralized clinical trial platform and mobile application powered to deliver stronger evidence of therapeutic efficacy and safety.

ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott Dixon as the company’s new Chief Commercial Officer. Dixon’s results-driven mindset is leading ObvioHealth’s commercial team in the successful global rollout of its next generation DCT platform and app.

ObvioHealth, a leading global Virtual Research Organization (VRO) pioneering end-to-end decentralized clinical trial solutions, announces today its inclusion in Inc. Magazine’s annual list of the nation’s fastest-growing private companies.

BYOD ePRO models deliver a range of benefits to clinical trial stakeholders, including increased engagement, reduced site team burden, and more.

Digital therapeutics are playing an increasing role in mental health care. Ensuring that these DTx products meet quality thresholds is key to effective care.